
|Articles|April 24, 2023
Flu Vaccine Cold Chain Case Study
Author(s)Spotsee
With millions of doses of the influenza vaccine being administered during the flu season, it's essential to make sure every vaccine is well protected. Discover how indicators can trigger only when product temperatures have exceeded maximums for a specific period of time. With at-a-glance ease, healthcare professionals can know instantly whether vaccines maintained proper temperatures during shipping adding confidence that vaccines have maintained their efficacy.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
2
New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models
3
Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths
4
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
5
